These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 12912954
1. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. Wong TS, Kwong DL, Sham JS, Tsao SW, Wei WI, Kwong YL, Yuen AP. Clin Cancer Res; 2003 Aug 01; 9(8):3042-6. PubMed ID: 12912954 [Abstract] [Full Text] [Related]
2. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient. Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP. Clin Cancer Res; 2003 Mar 01; 9(3):1033-8. PubMed ID: 12631603 [Abstract] [Full Text] [Related]
3. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Wong TS, Chang HW, Tang KC, Wei WI, Kwong DL, Sham JS, Yuen AP, Kwong YL. Clin Cancer Res; 2002 Feb 01; 8(2):433-7. PubMed ID: 11839660 [Abstract] [Full Text] [Related]
4. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP. Int J Cancer; 2003 Jul 20; 105(6):851-5. PubMed ID: 12767073 [Abstract] [Full Text] [Related]
5. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP. Mol Carcinog; 2003 Dec 20; 38(4):170-8. PubMed ID: 14639656 [Abstract] [Full Text] [Related]
6. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Wong TS, Kwong DL, Sham JS, Wei WI, Kwong YL, Yuen AP. Clin Cancer Res; 2004 Apr 01; 10(7):2401-6. PubMed ID: 15073117 [Abstract] [Full Text] [Related]
8. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX. Int J Cancer; 2003 Aug 10; 106(1):60-5. PubMed ID: 12794757 [Abstract] [Full Text] [Related]
9. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q. Oncogene; 2004 Jun 10; 23(27):4793-806. PubMed ID: 15122337 [Abstract] [Full Text] [Related]
10. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L. Oral Oncol; 2007 Jan 10; 43(1):82-7. PubMed ID: 16807071 [Abstract] [Full Text] [Related]
11. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma]. Ni HF, Jiang B, Zhou Z, Li Y, Yuan XY, Cao XL, Huang GW. Zhonghua Zhong Liu Za Zhi; 2016 Nov 23; 38(11):812-817. PubMed ID: 27998438 [Abstract] [Full Text] [Related]
12. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP. Cancer Res; 2001 May 15; 61(10):3877-81. PubMed ID: 11358799 [Abstract] [Full Text] [Related]
13. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Zhang Z, Sun D, Van do N, Tang A, Hu L, Huang G. Int J Cancer; 2007 Jan 01; 120(1):32-8. PubMed ID: 17013896 [Abstract] [Full Text] [Related]
14. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF. Clin Cancer Res; 2002 Aug 01; 8(8):2612-9. PubMed ID: 12171892 [Abstract] [Full Text] [Related]
15. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q. Oncogene; 2007 Feb 08; 26(6):934-44. PubMed ID: 16862168 [Abstract] [Full Text] [Related]
16. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP. Clin Cancer Res; 2002 Jan 08; 8(1):131-7. PubMed ID: 11801549 [Abstract] [Full Text] [Related]
17. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Tian F, Yip SP, Kwong DL, Lin Z, Yang Z, Wu VW. Cancer Epidemiol; 2013 Oct 08; 37(5):708-13. PubMed ID: 23790641 [Abstract] [Full Text] [Related]
18. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma. Wang T, Liu H, Chen Y, Liu W, Yu J, Wu G. J Exp Clin Cancer Res; 2009 Dec 30; 28(1):160. PubMed ID: 20042089 [Abstract] [Full Text] [Related]
19. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J. Cancer Detect Prev; 2008 Dec 30; 32(2):127-34. PubMed ID: 18632221 [Abstract] [Full Text] [Related]
20. [Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma]. Huang T, Du C, Yu N, Xiao X, Zhou X, Wang S, Huang G, Zhang Z. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug 30; 25(16):746-50. PubMed ID: 22070084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]